Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 14;2021(38):5367-5381.
doi: 10.1002/ejoc.202100894.

Chiral Phosphoric Acids as Versatile Tools for Organocatalytic Asymmetric Transfer Hydrogenations

Affiliations
Review

Chiral Phosphoric Acids as Versatile Tools for Organocatalytic Asymmetric Transfer Hydrogenations

Ádám Márk Pálvölgyi et al. European J Org Chem. .

Abstract

Herein, recent developments in the field of organocatalytic asymmetric transfer hydrogenation (ATH) of C=N, C=O and C=C double bonds using chiral phosphoric acid catalysis are reviewed. This still rapidly growing area of asymmetric catalysis relies on metal-free catalysts in combination with biomimetic hydrogen sources. Chiral phosphoric acids have proven to be extremely versatile tools in this area, providing highly active and enantioselective alternatives for the asymmetric reduction of α,β-unsaturated carbonyl compounds, imines and various heterocycles. Eventually, such transformations are more and more often used in multicomponent/cascade reactions, which undoubtedly shows their great synthetic potential and the bright future of organocatalytic asymmetric transfer hydrogenations.

Keywords: Asymmetric Transfer Hydrogenation; Catalysis; Chiral Phosphoric Acids; Metal-Free Hydrogenation; Organocatalysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The most typically used chiral phosphoric acids (top) and hydrogen sources (bottom) for asymmetric transfer hydrogenations.
Scheme 1
Scheme 1
Typical reaction mechanism of CPA‐catalyzed asymmetric transfer hydrogenations, illustrated with the ATH of ketimine A.
Scheme 2
Scheme 2
ATH of enals via asymmetric counteranion directed catalysis.
Scheme 3
Scheme 3
ATH of cyclic enones via asymmetric counteranion directed catalysis (A) and via “counterion enhanced catalysis” (B).
Scheme 4
Scheme 4
ATH of electron rich stryrenes (left) and the plausible intermediates (right bottom).
Scheme 5
Scheme 5
Asymmetric hydroarylation of electron rich stryrenes.
Scheme 6
Scheme 6
C 2‐symmetric imidodiphosphoric acid‐catalyzed ATH of aromatic ketals.
Scheme 7
Scheme 7
CPA‐catalyzed asymmetric transfer hydrogenation of prochiral ketones.
Scheme 8
Scheme 8
A CPA‐catalyzed asymmetric transfer hydrogenation of bulky aryl ketones.
Scheme 9
Scheme 9
Asymmetric transfer hydrogenation of ethyl ketimines.
Scheme 10
Scheme 10
Asymmetric transfer hydrogenation of fluorinated alkynyl ketimines.
Scheme 11
Scheme 11
Asymmetric transfer hydrogenation of fluorinated alkynyl ketimines via Ru/CPA combined catalysis.
Scheme 12
Scheme 12
Chiral DSI‐catalyzed asymmetric transfer hydrogenation of N‐alkyl imines.
Scheme 13
Scheme 13
Chiral DSI‐catalyzed asymmetric reductive condensation of N−H imines.
Scheme 14
Scheme 14
Synthesis of β‐aryl amines via reductive amination, relying on Hantzsch ester (A) or benzothiazoline reductants (B).
Scheme 15
Scheme 15
Strategies for the synthesis of α‐amino ketones via ATH and reductive amination.
Scheme 16
Scheme 16
Synthesis of polyheterocycles via reductive amination.
Scheme 17
Scheme 17
Reductive amination of β‐tetralones.
Scheme 18
Scheme 18
CPA‐catalyzed, ammonia borane‐mediated ATH of ketimines and β‐enamino esters.
Figure 2
Figure 2
Various biological activity of saturated N‐heterocycles.
Scheme 19
Scheme 19
Recent advances for the ATH of 49.
Scheme 20
Scheme 20
Formation of tetrahydroquinolines via AOX‐formation.
Scheme 21
Scheme 21
ATH of quinoline‐3‐amines.
Scheme 22
Scheme 22
pThr‐containing peptides with CPA scaffold for the ATH of 8‐aminoquinolines.
Scheme 23
Scheme 23
ATH of 3‐(trifluoromethyl)quinolines (top) and 3‐(trifluoromethyl‐thio)quinolines (bottom).
Scheme 24
Scheme 24
ATH of various N‐heterocycles catalyzed by SPINOL‐derived acid (S)‐CPA 8.
Scheme 25
Scheme 25
ATH of N‐heterocycles via Ru/CPA catalysis.
Scheme 26
Scheme 26
ATH of 1,4‐benzoxazines with in situ formed Hantzsch esters.
Scheme 27
Scheme 27
Catalyst immobilization strategies for the ATH of 1,4‐benzoxazines.
Scheme 28
Scheme 28
Synthesis of DHPDs.
Scheme 29
Scheme 29
Dehydroxy‐hydrogenation of 3‐indolylmethanol derivatives.
Scheme 30
Scheme 30
Synthesis of piperidines via asymmetric dearomatization/aza‐Friedel‐Crafts alkylation cascade reaction.
Scheme 31
Scheme 31
Dearomatization/ATH cascade for the synthesis of highly functionalized indole moieties (top) and the possible activation modes (bottom, A and B).
Scheme 32
Scheme 32
CPA‐mediated synthesis of 5,6‐dihydroindolo[1,2‐c]quinazolines (top) and its application for the preparation of α‐diamino acid derivatives (bottom).
Scheme 33
Scheme 33
Different concepts for the synthesis of spiroindolines via CPA‐catalyzed cascade reactions.
Scheme 34
Scheme 34
Synthesis of tetrahydroquinolines via dehydrative cyclization/ATH cascade reaction.
Scheme 35
Scheme 35
One‐pot synthesis of chiral quinolines via reduction of nitroarenes in a reduction/cyclization/reduction cascade.

Similar articles

Cited by

References

    1. Ojima I., Catalytic Asymmetric Synthesis, 3rd Edition, Wiley-VCH, Weinheim, 2010.
    1. Blaser H. U., Federsel H.-J., Asymmetric Catalysis on Industrial Scale: Challenges, Approaches and Solutions, 2nd Edition, Wiley-VCH, Weinheim, 2010.
    1. Yang J. W., Hechavarria Fonseca M. T., List B., J. Am. Chem. Soc. 2005, 127, 15036–15037. - PubMed
    1. Huang Y., Walji A. M., Larsen C. H., MacMillan D. W. C., J. Am. Chem. Soc. 2005, 127, 15051–15053. - PubMed
    1. Uraguchi D., Terada M., J. Am. Chem. Soc. 2004, 126, 5356–5357. - PubMed

LinkOut - more resources